Georgetown Transplant Institute — Washington D.C., District of Columbia

Georgetown Transplant Institute is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown Transplant Institute has participated in 2 clinical trials.

Therapeutic areas: Kidney Transplantation in Highly Sensitized Patients, Delayed Graft Function.

Sponsors: Hansa Biopharma AB, Quark Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown Transplant Institute?

Georgetown Transplant Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown Transplant Institute conducted?

Georgetown Transplant Institute has 2 clinical trials on record. Their work covers Kidney Transplantation in Highly Sensitized Patients, Delayed Graft Function.

Is Georgetown Transplant Institute accredited by Crixeo Health?

Georgetown Transplant Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown Transplant Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.